7.92
-0.08(-1.00%)
Currency In USD
| Previous Close | 8 |
| Open | 8.05 |
| Day High | 8.52 |
| Day Low | 7.92 |
| 52-Week High | 32.2 |
| 52-Week Low | 3.44 |
| Volume | 41,833 |
| Average Volume | 225,238 |
| Market Cap | 58.45M |
| PE | -1.51 |
| EPS | -5.23 |
| Moving Average 50 Days | 7.47 |
| Moving Average 200 Days | 9.67 |
| Change | -0.08 |
If you invested $1000 in Biodesix, Inc. (BDSX) since IPO date, it would be worth $30.91 as of November 18, 2025 at a share price of $7.92. Whereas If you bought $1000 worth of Biodesix, Inc. (BDSX) shares 3 years ago, it would be worth $282.86 as of November 18, 2025 at a share price of $7.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
GlobeNewswire Inc.
Oct 30, 2025 10:17 AM GMT
Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc.
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
GlobeNewswire Inc.
Oct 22, 2025 10:17 AM GMT
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testingLOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today
Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
GlobeNewswire Inc.
Oct 20, 2025 10:00 AM GMT
LOUISVILLE, Colo., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September 30, 2025 after the close of tra